Date published: 2025-12-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

GW 848687X (CAS 612831-24-0)

0.0(0)
Write a reviewAsk a question

CAS Number:
612831-24-0
Molecular Weight:
441.9
Molecular Formula:
C24H18ClF2NO3
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

GW 848687X, a potent and selective EP1 receptor antagonist (IC50 = 2.5 nM), exhibits over 400-fold selectivity for EP1 in comparison to other EP receptor subtypes, the PGD2 receptor, DP1, and the prostacyclin receptor, IP. Additionally, it demonstrates a 30-fold selectivity over the thromboxane A2 receptor, TP, and acts as a functional antagonist at higher concentrations. Its interactions with the FP and CRTH2/DP2 receptors remain uncharacterized. EP1 is a prostanoid receptor—which are a subtype of G protein-coupled receptors—that initiates cellular signaling upon interaction with PGE2.


GW 848687X (CAS 612831-24-0) References

  1. The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.  |  Giblin, GM., et al. 2007. Bioorg Med Chem Lett. 17: 385-9. PMID: 17084082
  2. Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.  |  Hall, A., et al. 2009. Bioorg Med Chem Lett. 19: 497-501. PMID: 19036582
  3. Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.  |  Hall, A., et al. 2009. Bioorg Med Chem Lett. 19: 2599-603. PMID: 19332369
  4. An evaluation of chemical photoreactivity and the relationship to photogenotoxicity.  |  Lynch, AM., et al. 2010. Regul Toxicol Pharmacol. 58: 219-23. PMID: 19914326
  5. An evaluation of chemical photoreactivity and the relationship to phototoxicity.  |  Kleinman, MH., et al. 2010. Regul Toxicol Pharmacol. 58: 224-32. PMID: 20600453
  6. EP4 receptor as a new target for bronchodilator therapy.  |  Buckley, J., et al. 2011. Thorax. 66: 1029-35. PMID: 21606476
  7. Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists.  |  Allan, AC., et al. 2011. Bioorg Med Chem Lett. 21: 4343-8. PMID: 21676612
  8. Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway.  |  Sancho, P., et al. 2011. Free Radic Biol Med. 51: 1789-98. PMID: 21907277
  9. EP4 receptors mediate prostaglandin E2, tumour necrosis factor alpha and interleukin 1beta-induced ion secretion in human and mouse colon mucosa.  |  Fairbrother, SE., et al. 2012. Eur J Pharmacol. 694: 89-97. PMID: 22732652
  10. Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.  |  Birrell, MA., et al. 2013. Br J Pharmacol. 168: 129-38. PMID: 22747912
  11. Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro.  |  Root, JA., et al. 2015. Eur J Pharmacol. 769: 274-9. PMID: 26607459
  12. Curcumin Ameliorates the Reduction Effect of PGE2 on Fibrillar β-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial Cells.  |  He, GL., et al. 2016. PLoS One. 11: e0147721. PMID: 26824354
  13. Inhibition of STAT3- and MAPK-dependent PGE2 synthesis ameliorates phagocytosis of fibrillar β-amyloid peptide (1-42) via EP2 receptor in EMF-stimulated N9 microglial cells.  |  He, GL., et al. 2016. J Neuroinflammation. 13: 296. PMID: 27871289
  14. Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells.  |  Li, C., et al. 2017. Mol Cancer Res. 15: 1318-1330. PMID: 28710231

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

GW 848687X, 500 µg

sc-295034
500 µg
$147.00

GW 848687X, 1 mg

sc-295034A
1 mg
$279.00